Joachim Burman

5.5k total citations · 1 hit paper
111 papers, 2.8k citations indexed

About

Joachim Burman is a scholar working on Pathology and Forensic Medicine, Oncology and Neurology. According to data from OpenAlex, Joachim Burman has authored 111 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Pathology and Forensic Medicine, 37 papers in Oncology and 30 papers in Neurology. Recurrent topics in Joachim Burman's work include Multiple Sclerosis Research Studies (68 papers), Polyomavirus and related diseases (31 papers) and Peripheral Neuropathies and Disorders (21 papers). Joachim Burman is often cited by papers focused on Multiple Sclerosis Research Studies (68 papers), Polyomavirus and related diseases (31 papers) and Peripheral Neuropathies and Disorders (21 papers). Joachim Burman collaborates with scholars based in Sweden, United Kingdom and United States. Joachim Burman's co-authors include Anders Svenningsson, Jan Fagius, Angelica Loskog, Johan Zelano, Moa Fransson, Jan Lycke, Kim Kultima, Raili Raininko, Henrik Zetterberg and Petra Nilsson and has published in prestigious journals such as JAMA, Circulation and Nature Communications.

In The Last Decade

Joachim Burman

105 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies

2019 346 citations Peter Alping, Joachim Burman et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joachim Burman Sweden	28	1.6k	814	686	669	507	111	2.8k
Fernando Dangond United States	26	1.3k 0.8×	667 0.8×	809 1.2×	614 0.9×	1.0k 2.0×	94	3.2k
Gavin Giovannoni United Kingdom	26	3.0k 1.8×	1.2k 1.5×	944 1.4×	1.1k 1.6×	335 0.7×	63	3.7k
Vissia Viglietta United States	23	2.0k 1.2×	882 1.1×	2.2k 3.1×	581 0.9×	662 1.3×	65	4.5k
Martin Toal United States	6	1.9k 1.2×	977 1.2×	685 1.0×	600 0.9×	370 0.7×	9	2.6k
Bhupendra Khatri United States	17	2.1k 1.3×	670 0.8×	503 0.7×	802 1.2×	1.1k 2.1×	50	2.9k
Gavin Giovannoni United Kingdom	10	3.5k 2.1×	1.4k 1.8×	1.1k 1.6×	1.2k 1.7×	735 1.4×	20	4.6k
Tatiana Plavina United States	22	1.4k 0.9×	1.4k 1.7×	480 0.7×	444 0.7×	350 0.7×	46	2.6k
Tracy Stites United States	14	2.3k 1.4×	583 0.7×	502 0.7×	833 1.2×	1.5k 3.1×	21	3.4k
A Wajgt Poland	10	2.5k 1.5×	1.3k 1.6×	872 1.3×	828 1.2×	371 0.7×	37	3.3k
Lixin Zhang-Auberson Switzerland	10	2.0k 1.2×	483 0.6×	423 0.6×	699 1.0×	1.3k 2.5×	13	2.7k

Countries citing papers authored by Joachim Burman

Since Specialization

Citations

This map shows the geographic impact of Joachim Burman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joachim Burman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joachim Burman more than expected).

Fields of papers citing papers by Joachim Burman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joachim Burman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joachim Burman. The network helps show where Joachim Burman may publish in the future.

Co-authorship network of co-authors of Joachim Burman

This figure shows the co-authorship network connecting the top 25 collaborators of Joachim Burman. A scholar is included among the top collaborators of Joachim Burman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joachim Burman. Joachim Burman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Carlson, Kristina, et al.. (2025). Patient-reported outcomes of quality of life before and after autologous hematopoietic stem cell transplantation for multiple sclerosis. Multiple Sclerosis Journal. 31(4). 455–463. 1 indexed citations

Ljungman, Per, et al.. (2025). Factors associated with outcomes following autologous haematopoietic stem cell transplantation for multiple sclerosis. Journal of Neurology Neurosurgery & Psychiatry. 96(10). 966–974. 2 indexed citations

Danfors, Torsten, et al.. (2024). Regional Metabolic Abnormalities in Autoimmune Encephalitis. Clinical Nuclear Medicine. 50(3). 208–213. 2 indexed citations

Nazir, Faisal Hayat, et al.. (2024). Micro-RNA Signature in CSF Before and After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis. Neurology Neuroimmunology & Neuroinflammation. 12(1). e200345–e200345.

Lindbäck, Johan, Alexander P. Benz, John W. Eikelboom, et al.. (2024). Neuroglial Biomarkers for Risk Assessment of Ischemic Stroke and Other Cardiovascular Events in Patients With Atrial Fibrillation Not Receiving Oral Anticoagulation. Journal of the American Heart Association. 14(2). e038860–e038860. 1 indexed citations

Piehl, Fredrik, Peter Alping, Simon Englund, et al.. (2024). COMBAT‐MS: A Population‐Based Observational Cohort Study Addressing the Benefit–Risk Balance of Multiple Sclerosis Therapies Compared with Rituximab. Annals of Neurology. 96(4). 678–693. 3 indexed citations

Киргизов, К. И., Joachim Burman, John A. Snowden, & Raffaella Greco. (2024). Autologous hematopoietic stem cell transplantation for pediatric autoimmune neurologic disorders. Handbook of clinical neurology. 202. 249–258. 1 indexed citations

Gallwitz, Maike, Jan Mulder, Annica J. Rasmusson, et al.. (2024). Three cases with chronic obsessive compulsive disorder report gains in wellbeing and function following rituximab treatment. Molecular Psychiatry. 30(4). 1396–1406. 1 indexed citations

Nazir, Faisal Hayat, et al.. (2024). Cerebrospinal fluid mtDNA concentrations are increased in multiple sclerosis and were normalized after intervention with autologous hematopoietic stem cell transplantation. Multiple Sclerosis and Related Disorders. 84. 105482–105482. 4 indexed citations

10.

Wiberg, Anna, Payam Emami Khoonsari, Henrik Carlsson, et al.. (2023). Autologous hematopoietic stem cell transplantation significantly alters circulating ceramides in peripheral blood of relapsing-remitting multiple sclerosis patients. Lipids in Health and Disease. 22(1). 97–97. 5 indexed citations

11.

Appel, Lieuwe, et al.. (2023). Image-derived input functions from dynamic 15O–water PET scans using penalised reconstruction. EJNMMI Physics. 10(1). 15–15. 6 indexed citations

12.

Ljungman, Per, Adjmal Nahimi, Arta Dreimane, et al.. (2023). Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study. Journal of Neurology Neurosurgery & Psychiatry. 95(2). 125–133. 16 indexed citations

13.

Burman, Joachim, et al.. (2022). Temporal trends of epilepsy in multiple sclerosis. Acta Neurologica Scandinavica. 146(5). 492–498. 5 indexed citations

14.

Burman, Joachim, et al.. (2019). Prognostic impact of epilepsy in multiple sclerosis. Multiple Sclerosis and Related Disorders. 38. 101497–101497. 22 indexed citations

15.

Forsberg, Lars, Anna Fält, Å. Berglund, et al.. (2019). Clinical effectiveness of dimethyl fumarate with focus on patients treated at least 36 months - a Swedish nationwide study of the long-term effectiveness and safety of dimethyl fumarate (IMSE5). Multiple Sclerosis Journal. 25. 316–317. 1 indexed citations

16.

Bergman, Joakim, Anders Svenningsson, Per Liv, & Joachim Burman. (2019). Poor correlation between protein levels in different CNS compartments in patients with progressive MS. Multiple Sclerosis Journal. 25. 432–433. 1 indexed citations

17.

Fält, Anna, Å. Berglund, Jan Hillert, et al.. (2018). A Swedish nationwide pharmaco-epidemiological and genetic study of the long-term safety and effectiveness of dimethyl fumarate (IMSE 5). Multiple Sclerosis Journal. 24. 699–700. 4 indexed citations

18.

Khoonsari, Payam Emami, Stephanie Herman, Marco Capuccini, et al.. (2018). Container-based bioinformatics with Pachyderm. Bioinformatics. 35(5). 839–846. 27 indexed citations

19.

Burman, Joachim, et al.. (2018). Risk of epilepsy after a single seizure in multiple sclerosis. European Journal of Neurology. 25(6). 854–860. 25 indexed citations

20.

Burman, Joachim & Anders Svenningsson. (2016). Cerebrospinal fluid concentration of Galectin-9 is increased in secondary progressive multiple sclerosis. Journal of Neuroimmunology. 292. 40–44. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact